{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AMP-activated protein kinase phosphorylation", "Davallia formosana", "diabetes", "glucose transporter 4", "hypertriglyceridemia"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26492243", "DateCompleted": {"Year": "2016", "Month": "07", "Day": "22"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "10", "Day": "20"}], "ELocationID": ["10.3390/ijms161024983"], "Language": ["eng"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "16", "Issue": "10", "PubDate": {"Year": "2015", "Month": "Oct", "Day": "20"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "(-)-Epicatechin-3-O-\u03b2-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.", "Pagination": {"StartPage": "24983", "EndPage": "25001", "MedlinePgn": "24983-5001"}, "Abstract": {"AbstractText": ["The purpose of this experiment was to determine the antidiabetic and lipid-lowering effects of (-)-epicatechin-3-O-\u03b2-D-allopyranoside (BB) from the roots and stems of Davallia formosana in mice. Animal treatment was induced by high-fat diet (HFD) or low-fat diet (control diet, CD). After eight weeks of HFD or CD exposure, the HFD mice were treating with BB or rosiglitazone (Rosi) or fenofibrate (Feno) or water through gavage for another four weeks. However, at 12 weeks, the HFD-fed group had enhanced blood levels of glucose, triglyceride (TG), and insulin. BB treatment significantly decreased blood glucose, TG, and insulin levels. Moreover, visceral fat weights were enhanced in HFD-fed mice, accompanied by increased blood leptin concentrations and decreased adiponectin levels, which were reversed by treatment with BB. Muscular membrane protein levels of glucose transporter 4 (GLUT4) were reduced in HFD-fed mice and significantly enhanced upon administration of BB, Rosi, and Feno. Moreover, BB treatment markedly increased hepatic and skeletal muscular expression levels of phosphorylation of AMP-activated (adenosine monophosphate) protein kinase (phospho-AMPK). BB also decreased hepatic mRNA levels of phosphenolpyruvate carboxykinase (PEPCK), which are associated with a decrease in hepatic glucose production. BB-exerted hypotriglyceridemic activity may be partly associated with increased mRNA levels of peroxisome proliferator activated receptor \u03b1 (PPAR\u03b1), and with reduced hepatic glycerol-3-phosphate acyltransferase (GPAT) mRNA levels in the liver, which decreased triacylglycerol synthesis. Nevertheless, we demonstrated BB was a useful approach for the management of type 2 diabetes and dyslipidemia in this animal model."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Pharmaceutical Science and Technology, College of Health Science, Central Taiwan University of Science and Technology, Taichung City 40601, Taiwan. ccshih@ctust.edu.tw."}], "LastName": "Shih", "ForeName": "Chun-Ching", "Initials": "CC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung City 40402, Taiwan. jwu@mail.cmu.edu.tw."}], "LastName": "Wu", "ForeName": "Jin-Bin", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Institute of Pharmaceutical Science and Technology, College of Health Science, Central Taiwan University of Science and Technology, Taichung City 40601, Taiwan. ccshih@ctust.edu.tw."}], "LastName": "Jian", "ForeName": "Jia-Ying", "Initials": "JY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Fong-Yuan Hospital, Department of Health, Executive Yuan, Fong-Yuan District, Taichung City 42055, Taiwan. keny71@pchome.com.tw."}], "LastName": "Lin", "ForeName": "Cheng-Hsiu", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jen Li Biotech Company Ltd., Taiping District, Taichung City 41143, Taiwan. jlbioaya@gmail.com."}], "LastName": "Ho", "ForeName": "Hui-Ya", "Initials": "HY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazolidinediones"}, {"RegistryNumber": "05V02F2KDG", "NameOfSubstance": "Rosiglitazone"}, {"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}, {"RegistryNumber": "U202363UOS", "NameOfSubstance": "Fenofibrate"}], "MeshHeadingList": [{"QualifierName": ["genetics", "metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug effects"], "DescriptorName": "Body Weight"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Fenofibrate"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Hyperlipidemias"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rosiglitazone"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Thiazolidinediones"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "O\u2019Rahilly S., Turner R.C., Matthews D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 1988;318:1225\u20131230. doi: 10.1056/NEJM198805123181902.", "ArticleIdList": ["10.1056/NEJM198805123181902", "3283553"]}, {"Citation": "Jakicic J.M., Jaramillo S.A., Balasubramanyam A., Bancroft B., Curtis J.M., Mathews A., Pereira M., Regensteiner J.G., Ribisl P.M. Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: Results from the Look AHEAD Study. Int. J. Obes. 2009;33:305\u2013316. doi: 10.1038/ijo.2008.280.", "ArticleIdList": ["10.1038/ijo.2008.280", "PMC2656590", "19153582"]}, {"Citation": "Mozaffarian D., Kamineni A., Carnethon M., Djousse L., Mukamal K.J., Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: The cardiovascular health study. Arch. Intern. Med. 2009;169:798\u2013807. doi: 10.1001/archinternmed.2009.21.", "ArticleIdList": ["10.1001/archinternmed.2009.21", "PMC2828342", "19398692"]}, {"Citation": "Petro A.E., Cotter J., Cooper D.A., Peters J.C., Surwit S.J., Surwit R.S. Fat, carbohydrate and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism. 2004;53:454\u2013457. doi: 10.1016/j.metabol.2003.11.018.", "ArticleIdList": ["10.1016/j.metabol.2003.11.018", "15045691"]}, {"Citation": "Editorial Committee of the Flora of Taiwan. Davallia S. Flora of Taiwan. 2nd ed. National Taiwan University; Taipei, Taiwan: 1994. p. 8."}, {"Citation": "Lin Y.Y., Kakisawa H., Shiobara Y., Nakanishi K. The structure of Davallic acid. Chem. Pharm. Bull. 1965;13:986\u2013995. doi: 10.1248/cpb.13.986.", "ArticleIdList": ["10.1248/cpb.13.986", "5867842"]}, {"Citation": "Hwang T.H., Kashiwada Y., Nonaka G.I., Nishioka I. Flavan-3-ol and proanthocyanidin allosides from Davallia divaricata. Phytochemistry. 1989;28:891\u2013896. doi: 10.1016/0031-9422(89)80138-4.", "ArticleIdList": ["10.1016/0031-9422(89)80138-4"]}, {"Citation": "Molinuevo M.S., Schurman L., McCarthy A.D., Cortizo A.M., Tolosa M.J., Gangoiti M.V., Arnol V., Sedlinsky C. Efect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies. J. Bone Miner. Res. 2010;25:211\u2013221. doi: 10.1359/jbmr.090732.", "ArticleIdList": ["10.1359/jbmr.090732", "19594306"]}, {"Citation": "Wongdee K., Charoenphandhu N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J. Diabetes. 2011;2:41\u201348. doi: 10.4239/wjd.v2.i3.41.", "ArticleIdList": ["10.4239/wjd.v2.i3.41", "PMC3083906", "21537459"]}, {"Citation": "Kim S.H., Choung S.Y. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (cinnamon bark) extract in C57BL/Ks db/db mice. Arch. Pharm. Res. 2010;33:325\u2013333. doi: 10.1007/s12272-010-0219-0.", "ArticleIdList": ["10.1007/s12272-010-0219-0", "20195835"]}, {"Citation": "Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab. 2007;5:237\u2013252. doi: 10.1016/j.cmet.2007.03.006.", "ArticleIdList": ["10.1016/j.cmet.2007.03.006", "17403369"]}, {"Citation": "Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002;3:267\u2013277. doi: 10.1038/nrm782.", "ArticleIdList": ["10.1038/nrm782", "11994746"]}, {"Citation": "Holmes B., Dohm G.L. Regulation of GLUT4 gene expression during exercise. Med. Sci. Sports Exerc. 2004;36:1202\u20131206. doi: 10.1249/01.MSS.0000132385.34889.FE.", "ArticleIdList": ["10.1249/01.MSS.0000132385.34889.FE", "15235326"]}, {"Citation": "Sriwijitkamol A., Coletta D.K., Wajcberg E., Balbontin G.B., Reyna S.M., Barrientes J., Eagan P.A., Jenkinson C.P., Cersosimo E., DeFronzo R.A., et al. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: A time-course and dose-response study. Diabetes. 2007;56:836\u2013848. doi: 10.2337/db06-1119.", "ArticleIdList": ["10.2337/db06-1119", "PMC2844111", "17327455"]}, {"Citation": "Mackenzie R.W., Elliot B.T. Akt/PKB activation and insulin signaling: A novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab. Syndr. Obes. 2014;7:55\u201364. doi: 10.2147/DMSO.S48260.", "ArticleIdList": ["10.2147/DMSO.S48260", "PMC3928478", "24611020"]}, {"Citation": "Jing M., Cheruvu V.K., Ismail-Beigi F. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. Am. J. Physiol. Cell Physiol. 2008;295:C1071\u2013C1082. doi: 10.1152/ajpcell.00040.2008.", "ArticleIdList": ["10.1152/ajpcell.00040.2008", "PMC2584987", "18701654"]}, {"Citation": "Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Investig. 2001;108:1167\u20131174. doi: 10.1172/JCI13505.", "ArticleIdList": ["10.1172/JCI13505", "PMC209533", "11602624"]}, {"Citation": "Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor \u03b31 (PPAR\u03b31) overexpression. Biol. Chem. 2003;278:498\u2013505. doi: 10.1074/jbc.M210062200.", "ArticleIdList": ["10.1074/jbc.M210062200", "12401792"]}, {"Citation": "Yki-J\u0201rvinen H. Thiazolidines. N. Engl. J. Med. 2004;351:1106\u20131118. doi: 10.1056/NEJMra041001.", "ArticleIdList": ["10.1056/NEJMra041001", "15356308"]}, {"Citation": "Martinez L., Berenguer M., Bruce M.C., Le Marchand-Brustel Y., Govers R. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling. Biochem. Pharmacol. 2010;79:1300\u20131309. doi: 10.1016/j.bcp.2009.12.013.", "ArticleIdList": ["10.1016/j.bcp.2009.12.013", "20026082"]}, {"Citation": "Damci T., Tatliagac S., Osar Z., Ilkova H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur. J. Intern. Med. 2003;14:357\u2013360. doi: 10.1016/S0953-6205(03)90001-X.", "ArticleIdList": ["10.1016/S0953-6205(03)90001-X", "14769493"]}, {"Citation": "Farnier M., Bonnefous F., Debbas N., Irvine A. Comparative efficacy and safety of micronised fenofibrate and simvastatin in patients with primary type Ha or IIb hyperlipidemia. Arch. Intern. Med. 1994;154:441\u2013449. doi: 10.1001/archinte.1994.00420040119015.", "ArticleIdList": ["10.1001/archinte.1994.00420040119015", "8117177"]}, {"Citation": "Hsu S.C., Huang C.J. Reduced fat mass in rats fed a high oleic acid-rich safflower oil diet is associated with changes in expression of hepatic PPAR\u03b1 and adipose SREBP-1c-regulated genes. J. Nutr. 2006;136:1779\u20131785.", "ArticleIdList": ["16772437"]}, {"Citation": "Srivastava R.A.K., Jahagirdar R., Azhar S., Sharma S., Bisgaier C.L. Peroxisome proliferator-activated receptor-\u03b1 selective ligand reduces adiposity, improves insulin sensitivity, and inhibits atherosclerosis in LDL receptor-deficient mice. Mol. Cell. Biochem. 2006;285:35\u201350. doi: 10.1007/s11010-005-9053-y.", "ArticleIdList": ["10.1007/s11010-005-9053-y", "16477380"]}, {"Citation": "Fryer L.G., Parbu-Patel A., Patel A. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002;277:25226\u201325232. doi: 10.1074/jbc.M202489200.", "ArticleIdList": ["10.1074/jbc.M202489200", "11994296"]}, {"Citation": "Ahmed M.H., Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD) Drug Discov. Today. 2007;12:740\u2013747. doi: 10.1016/j.drudis.2007.07.009.", "ArticleIdList": ["10.1016/j.drudis.2007.07.009", "17826687"]}, {"Citation": "Stein S.C., Woods A., Jones N.A., Davison M.D., Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 2000;345:437\u2013443. doi: 10.1042/bj3450437.", "ArticleIdList": ["10.1042/bj3450437", "PMC1220775", "10642499"]}, {"Citation": "Kleiner D.E., Brunt E.M., van Natta M., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u20131321. doi: 10.1002/hep.20701.", "ArticleIdList": ["10.1002/hep.20701", "15915461"]}, {"Citation": "Harte R.A., Kirk E.A., Rosenfeld M.E., LeBoeuf R.C. Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm. Metab. Res. 1999;31:570\u2013575. doi: 10.1055/s-2007-978797.", "ArticleIdList": ["10.1055/s-2007-978797", "10596967"]}, {"Citation": "Guo S. Insulin signaling, resistance, and metabolic syndrome: Insights from mouse models into disease mechanisms. J. Endocrinol. 2014;220:T1\u2013T23. doi: 10.1530/JOE-13-0327.", "ArticleIdList": ["10.1530/JOE-13-0327", "PMC4087161", "24281010"]}, {"Citation": "Zhu W., Cheng K.K., Vanhoutte P.M., Lam K.S., Xu A. Vascular effects of adiponectin: Molecular mechanisms and potential therapeutic intervention. Clin. Sci. 2008;114:361\u2013374. doi: 10.1042/CS20070347.", "ArticleIdList": ["10.1042/CS20070347", "18230060"]}, {"Citation": "Welsh G.I., Hers I., Berwick D.C., Dell G., Wherlock M., Birkin R., Leney S., Tavar\u00e9 J.M. Role of protein kinase B in insulin-regulated glucose uptake. Biochem. Soc. Trans. 2005;33:346\u2013349. doi: 10.1042/BST0330346.", "ArticleIdList": ["10.1042/BST0330346", "15787603"]}, {"Citation": "Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 2003;285:E685\u2013E692. doi: 10.1152/ajpendo.00253.2003.", "ArticleIdList": ["10.1152/ajpendo.00253.2003", "12959935"]}, {"Citation": "O\u2019Brien R.M., Printz R.L., Halmi N., Tiesinga J.J., Granner D.K. Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochim. Biophys. Acta. 1995;1264:284\u2013288. doi: 10.1016/0167-4781(95)00194-8.", "ArticleIdList": ["10.1016/0167-4781(95)00194-8", "8547315"]}, {"Citation": "Sutherland C., O\u2019Brien R.M., Granner D.K. New connections in the regulation of PEPCK gene expression by insulin. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1996;351:191\u2013199. doi: 10.1098/rstb.1996.0016.", "ArticleIdList": ["10.1098/rstb.1996.0016", "8650266"]}, {"Citation": "Kim Y.D., Park K.G., Lee Y.S., Park Y.Y., Kim D.K., Nedumaran B., Jang W.G., Cho W.J., Ha J., Lee I.K., et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008;57:306\u2013314. doi: 10.2337/db07-0381.", "ArticleIdList": ["10.2337/db07-0381", "17909097"]}, {"Citation": "Koeilevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C.R., Seckl J.R., et al. 11\u03b2-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA. 1997;94:14924\u201314929. doi: 10.1073/pnas.94.26.14924.", "ArticleIdList": ["10.1073/pnas.94.26.14924", "PMC25139", "9405715"]}, {"Citation": "Cases S., Smith S.J., Zheng Y.W., Myers H.M., Lear S.R., Sande E., Novak S., Collin C., Welch C.B., Lusis A.J., et al. Identification of a gene encoding an acyl CoA: Diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA. 1998;95:13018\u201313023. doi: 10.1073/pnas.95.22.13018.", "ArticleIdList": ["10.1073/pnas.95.22.13018", "PMC23692", "9789033"]}, {"Citation": "Oelkers P., Behari A., Cromley D., Billheimer J.T., Sturley S.L. Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes. J. Biol. Chem. 1998;273:26765\u201326771. doi: 10.1074/jbc.273.41.26765.", "ArticleIdList": ["10.1074/jbc.273.41.26765", "9756920"]}, {"Citation": "Stone S.J., Levin M.C., Zhou P., Han J., Walther T.C., Farese R.V., Jr. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 2009;284:5352\u20135361. doi: 10.1074/jbc.M805768200.", "ArticleIdList": ["10.1074/jbc.M805768200", "PMC2643492", "19049983"]}, {"Citation": "Meegalla R.L., Billheimer J.T., Cheng D. Concerted elevation of acyl-coenzyme A: Diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem. Biophys. Res. Commun. 2002;298:317\u2013323. doi: 10.1016/S0006-291X(02)02466-X.", "ArticleIdList": ["10.1016/S0006-291X(02)02466-X", "12413942"]}, {"Citation": "Yen C.L., Stone S.J., Koliwad S., Harris C., Farese R.V., Jr. Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008;49:2283\u20132301. doi: 10.1194/jlr.R800018-JLR200.", "ArticleIdList": ["10.1194/jlr.R800018-JLR200", "PMC3837458", "18757836"]}, {"Citation": "Lewin T.M., Granger D.A., Kim J.H., Coleman R.A. Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: Response to feeding status is unique in various rat tissues and is discordant with protein expression. Arch. Biochem. Biophys. 2001;396:119\u2013127. doi: 10.1006/abbi.2001.2604.", "ArticleIdList": ["10.1006/abbi.2001.2604", "11716470"]}, {"Citation": "Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000;20:1595\u20131599. doi: 10.1161/01.ATV.20.6.1595.", "ArticleIdList": ["10.1161/01.ATV.20.6.1595", "10845877"]}, {"Citation": "Wu X., Motoshima H., Mahadev K., Stalker T.J., Scalia R., Goldstein B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by globular domain of adiponectin in primary rat adipocytes. Diabetes. 2003;52:1355\u20131363. doi: 10.2337/diabetes.52.6.1355.", "ArticleIdList": ["10.2337/diabetes.52.6.1355", "12765944"]}, {"Citation": "Minokoshi Y., Kim Y.-B., Kahn B.B. Leptin stimulates fatty acid oxidation directly in white adipose tissue through activation of AMP-activated protein kinase. Diabetes. 2002;51:1375.", "ArticleIdList": ["0"]}, {"Citation": "Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., Yancopoulos G.D., Glass D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)/Akt/GSK3 pathways. Nat. Cell Biol. 2001;3:1009\u20131013. doi: 10.1038/ncb1101-1009.", "ArticleIdList": ["10.1038/ncb1101-1009", "11715022"]}, {"Citation": "Izumiya Y., Hopkins T., Morris C., Sato K., Zeng L., Viereck J., Hamilton J.A., Ouchi N., LeBrasseur N.K., Walsh K. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 2008;7:159\u2013172. doi: 10.1016/j.cmet.2007.11.003.", "ArticleIdList": ["10.1016/j.cmet.2007.11.003", "PMC2828690", "18249175"]}, {"Citation": "George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., Soos M.A., Murgatroyd P.R., Williams R.M., Acerini C.L., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304:1325\u20131328. doi: 10.1126/science.1096706.", "ArticleIdList": ["10.1126/science.1096706", "PMC2258004", "15166380"]}, {"Citation": "Ko Y.J., Wu J.B., Ho H.Y., Lin W.C. Antiosteoporotic activity of Davallia formosana. J. Ethnopharmacol. 2012;139:558\u2013565. doi: 10.1016/j.jep.2011.11.050.", "ArticleIdList": ["10.1016/j.jep.2011.11.050", "22155390"]}, {"Citation": "Li F., Xiong F.M., Li X., Lin H. Stimulative activity of Drynaria fortune (Kunez) J. Sm. Extracts and two of its flavonoids on the proliferation of osteoblastic like cells. Pharmazie. 2006;61:962\u2013965.", "ArticleIdList": ["17152991"]}, {"Citation": "Kuo Y.H., Lin C.H., Shih C.C. Ergostatrien-3\u03b2-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-Activated protein kinase phosphorylation. J. Agric. Food Chem. 2015;63:2479\u20132489. doi: 10.1021/acs.jafc.5b00073.", "ArticleIdList": ["10.1021/acs.jafc.5b00073", "25693659"]}, {"Citation": "Shih C.C., Shlau M.T., Lin C.H., Wu J.B. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. Phytother. Res. 2014;28:363\u2013371. doi: 10.1002/ptr.5003.", "ArticleIdList": ["10.1002/ptr.5003", "23610006"]}, {"Citation": "Shih C.C., Lin C.H., Wu J.B. Eriobotrya japonica improves hyperlipidaemia and reverses insulin resistance in high-fat-fed mice. Phytother. Res. 2010;24:1769\u20131780. doi: 10.1002/ptr.3143.", "ArticleIdList": ["10.1002/ptr.3143", "20564460"]}, {"Citation": "Shih C.C., Ciou J.L., Lin C.H., Wu J.B., Ho H.Y. Cell suspension culture of Eriobotrya japonica regulates the diabetic and hyperlipidemic signs of high-fat-fed mice. Molecules. 2013;18:2726\u20132753. doi: 10.3390/molecules18032726.", "ArticleIdList": ["10.3390/molecules18032726", "PMC6270550", "23455665"]}, {"Citation": "Lin C.H., Kuo Y.H., Shih C.C. Effects of Bofu-tsusho-san on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int. J. Mol. Sci. 2014;15:20022\u201320044. doi: 10.3390/ijms151120022.", "ArticleIdList": ["10.3390/ijms151120022", "PMC4264153", "25375187"]}, {"Citation": "Wu J.B., Kuo Y.H., Lin C.H., Ho Y.H., Shih C.C. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation. J. Agric. Food Chem. 2014;62:10717\u201310726. doi: 10.1021/jf503334d.", "ArticleIdList": ["10.1021/jf503334d", "25317836"]}, {"Citation": "Shih C.C., Lin C.H., Lin W.L., Wu J.B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J. Ethnopharmacol. 2009;123:82\u201390. doi: 10.1016/j.jep.2009.02.039.", "ArticleIdList": ["10.1016/j.jep.2009.02.039", "19429344"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "8", "Day": "16"}, {"Year": "2015", "Month": "9", "Day": "30"}, {"Year": "2015", "Month": "10", "Day": "12"}, {"Year": "2015", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "10", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["26492243", "PMC4632785", "10.3390/ijms161024983", "ijms161024983"]}}], "PubmedBookArticle": []}